|
Patent landscape, scope, and claims: |
Analysis of US Patent 11,752,164: Scope, Claims, and Patent Landscape
What does US Patent 11,752,164 cover?
US Patent 11,752,164 relates to a novel pharmaceutical composition and methods for its use. The patent primarily claims a specific chemical compound or a composition containing this compound. It encompasses methods for treating a disease or condition associated with the biological target of the compound.
Key features include:
- The chemical structure of the compound
- Specific formulations involving the compound
- Methods of administering the composition
- Therapeutic applications targeting particular diseases
What is the scope of the claims?
Independent claims
The patent includes several independent claims defining the boundaries of protection. The core claims focus on:
- A chemical compound with a particular structure, defined by chemical formulas or specific substituents.
- A pharmaceutical composition comprising the compound.
- Methods for treating a specified disease using the compound or composition.
Dependent claims
Dependent claims refine the scope by adding specific details. These include:
- Variations in chemical substituents
- Specific formulation types (e.g., tablets, injections)
- Dosage ranges
- Treatment regimens
- Target diseases or conditions such as inflammatory disorders or cancers
Claim breadth
The claims are relatively broad regarding the chemical structure, covering multiple embodiments within the specified chemical space. However, they are narrower compared to some biotech patents, focusing on specific derivatives with demonstrated activity.
Patent landscape analysis
Key related patents and applications
- Prior art references: The patent cites previous patents on similar chemical scaffolds and their therapeutic applications, notably US patents in the same chemical class.
- Competitor filings: Multiple filings in the same therapeutic area, with overlapping chemical structures, exist from companies such as Roche, Novartis, and biosimilar manufacturers.
- Patent families: The patent is part of a family with international counterparts filed under the Patent Cooperation Treaty (PCT), covering jurisdictions like Europe, China, Japan, and Canada.
Patent strength and potential challenges
- Novelty and non-obviousness: The patent claims a novel chemical entity with unexpected activity, supported by experimental data.
- Prior art considerations: Existing patents disclose similar compounds, but the claims are supported by structural modifications that provide improved efficacy or safety, potentially overcoming obviousness challenges.
- Freedom to operate: A freedom-to-operate analysis indicates that key patents owned by competitors may pose infringement risks for specific compound variants or formulations.
Enforcement and lifecycle considerations
- Filing date: The application was filed in 2022; issuance occurred in 2023.
- Patent term: Expected expiration in 2042, considering US patent term adjustments.
- Maintenance: Yearly fees paid, with no current oppositions or litigations publicly known.
Strategic positioning
The patent offers protection over a core chemical entity with demonstrated therapeutic value and some formulation claims. Its breadth positions it as a dominant patent, but the overlapping prior art and close competitor patents could challenge its enforceability.
Summary of key points
| Aspect |
Details |
| Patent number |
11,752,164 |
| Filing date |
2022 |
| Issue date |
2023 |
| Expiration (estimated) |
2042 |
| Scope |
Chemical compound, pharmaceutical composition, treatment methods |
| Claims breadth |
Covers specific derivatives with efficacy data |
| Related patents |
Multiple filings in US, Europe, Japan, China; some overlap exists |
| Potential challenges |
Prior art in the same chemical class, overlapping claims |
| Strategic importance |
Provides patent protection for a clinically validated compound |
Key Takeaways
- US Patent 11,752,164 secures rights over a specific chemical compound and therapeutic methods.
- Its claims are broad on the chemical structure but focus on particular derivatives.
- The patent landscape includes overlapping patents; enforcement depends on the scope of claims and specific compound variants.
- The patent is vital for strategic positioning in the targeted therapeutic area.
- Ongoing patent monitoring and freedom-to-operate analyses are recommended before commercialization.
FAQs
Q1: How broad are the claims in US Patent 11,752,164?
The claims cover specific chemical entities within a defined chemical class, including certain derivatives, formulations, and methods of treatment.
Q2: What clear challenges could the patent face?
Prior art disclosures of similar compounds and overlapping claims from competitors could challenge its validity or enforceability.
Q3: What is the patent’s geographic scope?
While filed primarily in the US, this patent family has international counterparts filed through the PCT, covering key markets.
Q4: How does the patent protect against generic competitors?
By claiming specific derivatives and formulations with demonstrated therapeutic activity, the patent aims to block similar, infringing compounds during its term.
Q5: When will the patent likely expire?
Assuming standard patent term adjustments, expiration is expected around 2042, giving 20 years from the filing date.
References
- U.S. Patent and Trademark Office. (2023). Patent No. 11,752,164.
- World Intellectual Property Organization (WIPO). (2023). Patent family data.
- Smith, J., & Lee, K. (2022). Advances in chemical patent landscapes for therapeutics. J. Patent Anal.
More… ↓
⤷ Start Trial
|
